Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 30, 2026 02:33 ET | Source: AB2 Bio Ltd

AB2 Bio receives $30 million from Nippon Shinyaku for exclusive U.S. commercialization rights to Tadekinig Alfa

AB2 Bio receives $30 million from Nippon Shinyaku for exclusive U.S. commercialization rights to Tadekinig Alfa Nippon Shinyaku exercises its exclusive U.S. commercialization option for Tadekinig...
July 21, 2026 09:00 ET | Source: NeuroSigma, Inc.

NeuroSigma Announces U.S. Commercial Launch of Second-Generation Monarch® eTNS System for Pediatric ADHD

U.S. Commercial launch of Gen 2 Monarch System commencing today, July 21, 2026Gen 2 Monarch device provides an enhanced patient experience while delivering clinically proven therapeutic stimulation of...
July 07, 2026 04:30 ET | Source: Custom Market Insights

[Latest] Global Infant Medicine Syringes Market Size/Share Worth USD 1108.13 Million by 2035 at a 5.89% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, July 07, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Infant Medicine Syringes Market Size, Trends and Insights By Type (Oral Syringes,...
July 06, 2026 15:30 ET | Source: Custom Market Insights

[Latest] Global Infant Heart Monitor Market Size/Share Worth USD 7.93 Billion by 2035 at a 10.85% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, July 07, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Infant Heart Monitor Market Size, Trends and Insights By Product Type (Video...
July 01, 2026 19:30 ET | Source: Custom Market Insights

[Latest] Global Neonatal Infant Care Market Size/Share Worth USD 5.59 Billion by 2035 at a 6.21% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, July 02, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Neonatal Infant Care Market Size, Trends and Insights By Product Type...
June 29, 2026 10:30 ET | Source: Custom Market Insights

[Latest] Global Neonatal Infant Care Market Size/Share Worth USD 8.94 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, June 29, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Neonatal Infant Care Market Size, Trends and Insights By Product Type...
June 25, 2026 08:01 ET | Source: Baby Innovation Awards

Lab52 n-HAP Kids Toothpaste Named “Toothpaste Product of the Year” In 2026 Baby Innovation Awards

LOS ANGELES, June 25, 2026 (GLOBE NEWSWIRE) -- The 2026 Baby Innovation Awards, an independent recognition platform highlighting the most innovative companies, services, and products in the highly...
June 23, 2026 09:00 ET | Source: NeOnc Technologies Holdings, Inc.

NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone

NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone
June 04, 2026 01:00 ET | Source: Pharming Group N.V.

Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS

Pharming today announced that the U.S. FDA accepted its sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
May 21, 2026 14:50 ET | Source: ODDIFACT

ODDIFACT Receives European Commission Orphan Drug Designation for Infliximab in Kawasaki Disease

ODDIFACT obtient la désignation médicament orphelin de l'EMA pour l'infliximab dans la maladie de Kawasaki, après la FDA. Essai KIDCARE dans The Lancet.